High Creatinine Levels: Causes, Kidney Function, eGFR, BUN, Laboratory Interpretation & Clinical Case Studies (2026)

 

Last updated: August 17, 2026

High creatinine levels are among the most common abnormal findings encountered in clinical chemistry and kidney-function testing. Serum creatinine is widely used because it is inexpensive, routinely available, and closely linked to renal filtration. Yet a high result does not automatically mean kidney failure, and a normal result does not always exclude clinically important kidney disease.

Correct interpretation requires integration of serum creatinine, eGFR, BUN, electrolytes, urinalysis, UACR, previous results, muscle mass, hydration, medications, diet, analytical method, interferences, and quality-control status. This MedLab Academy guide provides a laboratory-centered approach to high creatinine, including AKI versus CKD, CKD-EPI 2021 eGFR, cystatin C, Jaffé versus enzymatic methods, IDMS traceability, QC troubleshooting, delta checks, interpretation algorithms, and clinical cases.

Medical Disclaimer: This article is for educational purposes for medical laboratory professionals, students, and healthcare learners. Laboratory results must be interpreted using the performing laboratory’s validated method, reference information, clinical context, and applicable guidelines. It is not a substitute for medical diagnosis or treatment.

Table of Contents

1. What Is Creatinine?
2. Why Is a Creatinine Test Ordered?
3. Creatinine Normal Range and Units
4. Causes of High Creatinine
5. Creatinine and eGFR
6. eGFR Categories
7. AKI vs CKD
8. BUN and Creatinine
9. Cystatin C
10. Urine Albumin-to-Creatinine Ratio
11. Preanalytical Factors
12. Jaffé vs Enzymatic Methods
13. Analytical Interferences
14. Standardization and IDMS
15. Quality Control
16. Delta Checks
17. Interpretation Algorithm
18. Associated Tests
19. Special Populations
20. Creatinine and Diabetes
21. Kidney Function and Vitamin D
22. Clinical Case Studies
23. Common Interpretation Errors
24. Laboratory Checklist
25. Key Takeaways
26. Frequently Asked Questions
27. Related Guides
28. References

1. What Is Creatinine?

Creatinine is a nitrogenous waste product generated largely from the spontaneous conversion of creatine and phosphocreatine in skeletal muscle. It enters the circulation at a relatively steady rate in many individuals and is removed predominantly by the kidneys. Because serum creatinine rises when renal clearance falls, it is one of the most widely used laboratory markers in the assessment of kidney function.

However, creatinine is not a direct measurement of glomerular filtration rate (GFR). Its concentration is influenced by kidney filtration as well as muscle mass, age, sex, diet, hydration, medications, and analytical methodology. A result must therefore be interpreted in context rather than classified simply as “normal” or “high.”

Creatinine is commonly included in a basic or comprehensive metabolic panel and is often interpreted together with eGFR, blood urea nitrogen (BUN), electrolytes, urinalysis and urine albumin-to-creatinine ratio (UACR). For a broader view of urine findings, see Urinalysis (UA): Physical, Chemical & Microscopic Examination.

↑ Back to Table of Contents

2. Why Is a Creatinine Test Ordered?

Serum creatinine testing is used to assess kidney health, investigate suspected acute or chronic kidney dysfunction, monitor established kidney disease, evaluate possible medication-related nephrotoxicity, and support calculation of eGFR. It may also be ordered in patients with diabetes, hypertension, cardiovascular disease, dehydration, urinary obstruction, severe infection, or other conditions that can affect renal perfusion or filtration.

A single creatinine result cannot by itself establish the cause, chronicity, or severity of kidney disease. Serial measurements and related laboratory data are often more informative.

↑ Back to Table of Contents

3. Creatinine Normal Range and Units

Creatinine reference intervals vary by laboratory, analytical method, population, age, sex, and muscle mass. Laboratories should report and interpret results using their own validated reference interval.

Measurement	Common unit	Interpretive note
Serum creatinine	mg/dL	Commonly used in the United States and some other settings
Serum creatinine	µmol/L	Common SI unit internationally
eGFR	mL/min/1.73 m²	Estimated filtration normalized to body surface area

Unit conversion: creatinine in mg/dL × 88.4 ≈ µmol/L. Conversely, µmol/L ÷ 88.4 ≈ mg/dL.

Published example ranges should never replace the performing laboratory’s interval. Creatinine may be lower in people with reduced muscle mass and higher in muscular individuals even when kidney filtration is not proportionally different.

↑ Back to Table of Contents

4. What Causes High Creatinine Levels?

An increased serum creatinine concentration can reflect reduced glomerular filtration, but the differential diagnosis is broader. The first task is to determine whether the change is likely renal, prerenal, postrenal, physiological, medication-related, or analytical.

4.1 Reduced kidney filtration

Acute kidney injury (AKI) and chronic kidney disease (CKD) can both increase serum creatinine. The pattern over time, urine findings, clinical history, and eGFR help distinguish acute from chronic processes.

4.2 Dehydration and reduced renal perfusion

Volume depletion can reduce renal blood flow and GFR, causing creatinine and often BUN to rise. Clinical volume status and the overall biochemical pattern are important.

4.3 Urinary tract obstruction

Obstruction to urine flow may produce postrenal kidney dysfunction. Depending on the setting, causes include stones, prostatic obstruction, tumors, or other structural abnormalities.

4.4 Muscle injury and intense exercise

Creatinine production is related to muscle. Severe muscle injury and rhabdomyolysis can increase creatinine and may simultaneously cause true AKI. Creatine kinase and urine findings can provide additional clues.

4.5 Diet and supplements

A recent meat-rich meal can transiently influence serum creatinine, and creatine supplementation can complicate interpretation in some patients.

4.6 Medications

Some drugs can increase serum creatinine by reducing tubular secretion without an equivalent fall in true GFR, while others may cause genuine kidney injury. Medication history is therefore essential.

↑ Back to Table of Contents

5. Creatinine and eGFR: Why eGFR Matters

Serum creatinine alone is an imperfect filtration marker. Estimated glomerular filtration rate (eGFR) combines a filtration marker with demographic variables to provide a more clinically useful estimate of kidney filtration.

The 2021 CKD-EPI creatinine equation is a race-free equation using standardized serum creatinine, age, and sex. Laboratories implementing eGFR should ensure that creatinine measurement is traceable to appropriate reference systems and that the equation is correctly programmed and verified.

Laboratory Pearl: A creatinine value that falls within a population reference interval does not automatically exclude reduced kidney function. eGFR and urine markers can reveal clinically important abnormalities that are not obvious from creatinine alone.

↑ Back to Table of Contents

6. eGFR Categories and CKD Interpretation

eGFR is commonly categorized for CKD evaluation, but CKD diagnosis requires evidence of abnormal kidney structure or function that persists for the required duration; an isolated eGFR result should not automatically be labeled chronic kidney disease.

GFR category	eGFR (mL/min/1.73 m²)	Description
G1	≥90	Normal or high
G2	60–89	Mildly decreased
G3a	45–59	Mildly to moderately decreased
G3b	30–44	Moderately to severely decreased
G4	15–29	Severely decreased
G5	<15	Kidney failure category

Albuminuria category is also important for CKD risk assessment. A complete laboratory evaluation often combines eGFR with UACR rather than relying on creatinine alone.

↑ Back to Table of Contents

7. High Creatinine: AKI vs CKD

Feature	AKI pattern	CKD pattern
Time course	Hours to days	Persistent/chronic
Previous creatinine	May show recent rise	May show long-standing elevation
eGFR	May change rapidly and be less reliable during non-steady state	Useful for staging when kidney function is stable
Urinalysis	May provide acute diagnostic clues	May show persistent albuminuria or other abnormalities
Clinical context	Dehydration, sepsis, nephrotoxins, obstruction, acute illness	Diabetes, hypertension, chronic glomerular or structural disease

During rapidly changing kidney function, creatinine is not at steady state; consequently, a creatinine-based eGFR can be misleading if interpreted as though filtration were stable. Trend review is essential.

Inflammatory and infectious contexts may also require other biomarkers. Related reading: {A("pct")} and {A("crp")}.

↑ Back to Table of Contents

8. Creatinine, BUN and the BUN/Creatinine Relationship

BUN and creatinine are often ordered together, but they are affected by different nonrenal factors. BUN can vary with protein intake, catabolic state, gastrointestinal bleeding, liver urea synthesis, hydration, and medications. Creatinine is more strongly influenced by muscle-related factors.

The BUN/creatinine relationship may provide contextual clues, but it should not be treated as a stand-alone diagnostic test. The clinical picture, urine studies, hemodynamics, medications, and serial measurements remain essential.

Because liver function can influence urea production and because severe liver disease may alter creatinine interpretation through reduced muscle mass, see the {A("lft")} guide when hepatic disease is part of the differential diagnosis.

↑ Back to Table of Contents

9. Cystatin C and Combined eGFR

Cystatin C is an alternative endogenous filtration marker. It is less directly dependent on muscle mass than creatinine, although it has its own non-GFR determinants. In selected situations where creatinine-based eGFR may be less accurate, cystatin C can improve assessment.

Current kidney guidance supports the use of combined creatinine–cystatin C equations in circumstances where greater accuracy is required or where creatinine may be misleading. The 2021 CKD-EPI creatinine–cystatin C equation is race-free and requires standardized measurements of both markers.

↑ Back to Table of Contents

10. Urine Albumin-to-Creatinine Ratio (UACR)

Kidney assessment is incomplete if filtration is considered without markers of kidney damage. The urine albumin-to-creatinine ratio (UACR) uses urine creatinine to normalize albumin concentration for urine dilution and is a key tool for detecting albuminuria.

Albuminuria can be present even when serum creatinine is not markedly elevated. This is particularly relevant in diabetes and hypertension. For diabetes-related laboratory monitoring, see HbA1c: Diabetes Diagnosis, Monitoring & QC.

Urine dipstick, microscopy, protein, blood, casts, and other findings may provide additional diagnostic information; see Urinalysis (UA): Physical, Chemical & Microscopic Examination.

↑ Back to Table of Contents

11. Preanalytical Factors Affecting Creatinine

Preanalytical review should include patient identification, specimen type, collection quality, timing, hydration, recent diet, strenuous exercise, muscle injury, supplements, and medications. Serum or plasma acceptability depends on the specific analyzer and manufacturer instructions.

Recent cooked meat ingestion can transiently increase serum creatinine. Intense exercise may also affect the result. In serial monitoring, large unexplained changes should prompt review of collection conditions and patient context before assuming true deterioration in kidney function.

↑ Back to Table of Contents

12. Laboratory Methods: Jaffé vs Enzymatic Creatinine

12.1 Jaffé reaction

The Jaffé method is based on the reaction of creatinine with picrate under alkaline conditions to produce a colored complex. It is widely used and cost-effective, but non-creatinine chromogens can affect specificity. Modern compensated kinetic Jaffé methods reduce some historical bias, yet method-dependent interference remains important.

12.2 Enzymatic methods

Enzymatic assays use enzyme reactions designed to improve specificity for creatinine. They may have advantages in selected populations or concentration ranges, but they are not completely free from interference.

Feature	Jaffé	Enzymatic
Principle	Alkaline picrate reaction	Enzyme-based reaction sequence
Specificity	More susceptible to non-creatinine chromogens	Generally improved, but method-dependent
Cost	Often lower	Often higher
Standardization	Both should be appropriately standardized/traceable for eGFR use

↑ Back to Table of Contents

13. Analytical Interferences and False Creatinine Changes

Interference is assay-specific. Laboratories should rely on the manufacturer’s interference studies, local verification, and instrument flags rather than assuming all Jaffé or enzymatic assays behave identically.

Potential issues include hemolysis, lipemia, icterus, ketones, glucose, proteins, selected drugs, and other method-specific interferents. The direction and magnitude of bias depend on assay architecture and concentration.

For a detailed approach to specimen hemolysis and interference indices, see Hemolysis in Clinical Chemistry.

Laboratory Pearl: An unexpected creatinine change that is inconsistent with the patient’s clinical status should trigger review of specimen integrity, analytical flags, QC, calibration, previous results, medications, and—when justified—repeat or alternative-method testing.

↑ Back to Table of Contents

14. Creatinine Standardization and IDMS Traceability

Creatinine standardization is critical because relatively small analytical biases can meaningfully alter eGFR, especially near clinical decision thresholds. Contemporary eGFR equations are intended for use with standardized creatinine measurements.

Clinical laboratories should verify calibration traceability, method performance, and eGFR calculation logic. Changes in reagent lot, calibrator lot, analyzer, or methodology require appropriate quality procedures and may warrant assessment of comparability.

↑ Back to Table of Contents

15. Quality Control for Creatinine Testing

Patient creatinine and eGFR reporting should occur only when the analytical system is under acceptable control. Internal QC should cover clinically relevant concentrations and be reviewed using the laboratory’s validated QC strategy.

Key elements include control means, standard deviations, coefficients of variation, Levey–Jennings charts, rejection rules, calibration status, lot changes, maintenance, and trend/shift detection. For a deeper review, see Internal Quality Control (IQC): Westgard Rules & Levey–Jennings Charts and Laboratory Quality Indicators (QIs): KPIs, ISO 15189 & Quality Management.

What if creatinine QC is out of range?

1. Stop release of affected patient results.
2. Review the QC rule violated and the magnitude/pattern of error.
3. Check control material, storage, expiration and preparation.
4. Review reagent and calibrator lots, stability and expiration.
5. Check calibration and analyzer status.
6. Review maintenance and recent changes.
7. Repeat QC only when scientifically justified; do not repeatedly rerun controls without investigating the cause.
8. Correct the problem, document actions, and confirm acceptable performance before reporting.
9. Assess previously reported patient results if evidence suggests the problem began earlier.

↑ Back to Table of Contents

16. Delta Checks and Unexpected Creatinine Results

A delta check compares the current result with a previous result from the same patient. A significant creatinine delta can represent real clinical deterioration or improvement, but it can also indicate preanalytical error, specimen misidentification, method change, interference, or data-entry problems.

Delta limits should be locally validated and interpreted with the time interval and clinical context. A patient with evolving AKI may legitimately show a rapid rise, whereas a dramatic unexplained change in an otherwise stable outpatient warrants verification.

↑ Back to Table of Contents

17. Laboratory Interpretation Algorithm for High Creatinine

1. Confirm patient and specimen identity.
2. Confirm units and reference interval. Distinguish mg/dL from µmol/L.
3. Review QC and calibration. Do not interpret patient results from an uncontrolled analytical run.
4. Compare with previous creatinine. Determine whether the change is new, progressive, improving, or chronic.
5. Review eGFR. Remember that eGFR is less reliable when creatinine is rapidly changing.
6. Review BUN and electrolytes. Potassium, bicarbonate and other chemistry results may affect urgency and interpretation.
7. Review urinalysis and UACR. Look for albuminuria, blood, protein, casts and other clues.
8. Consider prerenal, intrinsic renal and postrenal causes.
9. Review medications, diet, supplements, exercise and muscle injury.
10. Investigate analytical discordance. Consider interference, repeat testing, dilution or an alternative method when appropriate.
11. Escalate critical or rapidly worsening patterns according to laboratory policy.

↑ Back to Table of Contents

18. Important Tests to Interpret With Creatinine

Test	Why it matters
eGFR	Estimates kidney filtration from standardized markers and patient variables
BUN	Adds context regarding nitrogen handling, hydration and catabolic state
Potassium	Can become dangerously elevated in significant kidney dysfunction
Bicarbonate/total CO₂	Helps assess acid-base consequences
Urinalysis	Detects protein, blood, cells, casts and other clues
UACR	Detects and quantifies albuminuria
Cystatin C	Can refine GFR estimation in selected circumstances
CK	Important when rhabdomyolysis is suspected
CBC	May add context in chronic disease, bleeding, infection or systemic illness

Related laboratory reading: Complete Blood Count (CBC): Parameters & Interpretation, ESR: Complete Laboratory Guide, and High Ferritin Levels: Causes & Laboratory Interpretation.

↑ Back to Table of Contents

19. Special Populations and Limitations of Creatinine

Older adults and low muscle mass

Low creatinine production can mask impaired filtration. A “normal” creatinine should not be interpreted without eGFR and clinical context.

High muscle mass

Muscular individuals may have higher baseline creatinine that does not necessarily indicate proportionate kidney dysfunction.

Amputation, cachexia and neuromuscular disease

Creatinine-based estimates may be less reliable when muscle mass differs markedly from the populations used to derive equations.

Pregnancy

Renal physiology changes substantially during pregnancy. Creatinine and eGFR require pregnancy-specific clinical interpretation; standard adult eGFR equations are not simply interchangeable with direct obstetric assessment.

Children

Pediatric GFR estimation uses age-appropriate equations and laboratory practices rather than blindly applying adult equations.

↑ Back to Table of Contents

20. Creatinine and Diabetes

Diabetes is a major clinical context for kidney assessment. Serum creatinine and eGFR evaluate filtration, while UACR detects albuminuria. These markers complement rather than replace glycemic assessment.

For laboratory interpretation of long-term glycemic control, see HbA1c: Diabetes Diagnosis, Monitoring & QC.

↑ Back to Table of Contents

21. Kidney Function and Vitamin D Metabolism

The kidneys participate in activation of vitamin D, and advanced CKD can disrupt calcium, phosphate, parathyroid hormone and vitamin D metabolism. Consequently, a patient with reduced eGFR may require a broader mineral and bone laboratory assessment.

See the MedLab Academy Vitamin D Blood Test: 25-Hydroxy Vitamin D Levels & Laboratory Interpretation and High Alkaline Phosphatase (ALP) Levels guides for related laboratory interpretation.

↑ Back to Table of Contents

22. Clinical Case Studies

Case 1: Dehydration with increased creatinine

A patient with vomiting and poor oral intake has a new creatinine increase compared with baseline and elevated BUN. The laboratory pattern may be compatible with reduced renal perfusion, but the result is not diagnostic by itself. Serial chemistry after clinical management and assessment of urine findings can help clarify the trajectory.

Case 2: High creatinine in a muscular adult

A physically active patient with high muscle mass has mildly increased creatinine but no previous kidney disease. Before labeling CKD, review eGFR limitations, urine albumin, urinalysis, trend, diet, supplements, and consider a confirmatory filtration marker such as cystatin C when clinically appropriate.

Case 3: Rapid rise during severe infection

A hospitalized patient with sepsis shows a rapidly rising creatinine. Because kidney function is not at steady state, eGFR should not be treated as a precise stable measurement. Serial creatinine, urine output, electrolytes and clinical hemodynamics are more informative. Procalcitonin may be used in selected infection-related contexts but does not diagnose AKI.

Case 4: Creatinine rise with hyperkalemia

A substantial creatinine increase accompanied by significant hyperkalemia requires prompt clinical attention. The laboratory should verify analytical validity and follow critical-result policies where applicable.

Case 5: Unexpected isolated creatinine jump

A stable outpatient has a large creatinine increase inconsistent with previous results and clinical status. Review patient identification, specimen quality, QC, analyzer flags, method interference, medication changes and recent exercise or meat intake. Repeat testing or confirmation may be appropriate.

Case 6: Normal creatinine but abnormal UACR

A patient with diabetes has creatinine within the laboratory reference interval but persistent albuminuria. The normal creatinine does not exclude kidney damage. eGFR and UACR together provide more complete risk information.

↑ Back to Table of Contents

23. Common Creatinine Interpretation Errors

• Error 1: Diagnosing CKD from one elevated creatinine result.
• Error 2: Assuming normal creatinine excludes kidney disease.
• Error 3: Ignoring muscle mass, diet, exercise and supplements.
• Error 4: Treating eGFR as exact during rapidly changing AKI.
• Error 5: Ignoring UACR and urinalysis.
• Error 6: Comparing results from different methods without considering analytical bias.
• Error 7: Ignoring interference or specimen quality.
• Error 8: Releasing results while QC is unacceptable.
• Error 9: Treating the BUN/creatinine ratio as a definitive diagnosis.
• Error 10: Failing to review previous results and delta change.

↑ Back to Table of Contents

24. Practical Laboratory Checklist Before Releasing Creatinine

• Correct patient and specimen?
• Correct units and reference interval?
• QC acceptable?
• Calibration valid?
• Result within analytical measurement range?
• Any hemolysis, icterus or lipemia concerns?
• Any analyzer flags?
• Does the result require dilution or repeat analysis?
• Is the eGFR equation appropriate and correctly calculated?
• Is the change consistent with previous results?
• Could medication, diet, supplements, exercise or muscle injury contribute?
• Are BUN, potassium, bicarbonate, urinalysis and UACR available?
• Does the result meet local critical or urgent notification criteria?

↑ Back to Table of Contents

25. Key Laboratory Takeaways

• Creatinine is a useful but imperfect endogenous filtration marker.
• High creatinine often reflects reduced kidney clearance but is not specific for one diagnosis.
• eGFR generally provides more kidney-function information than creatinine alone when kidney function is stable.
• The 2021 CKD-EPI creatinine equation is race-free and requires standardized creatinine.
• Combined creatinine–cystatin C eGFR can improve accuracy in selected situations.
• UACR complements eGFR by identifying albuminuria.
• AKI and CKD must be distinguished using time course, previous results, clinical context and other tests.
• Jaffé and enzymatic creatinine methods have different analytical characteristics and interferences.
• QC and calibration must be acceptable before patient results are released.
• Unexpected results require review of preanalytical, analytical and biological factors.

↑ Back to Table of Contents

26. Frequently Asked Questions

What does a high creatinine level mean?

High creatinine may indicate reduced kidney filtration, but dehydration, urinary obstruction, muscle injury, intense exercise, diet, supplements, medications and analytical factors can also contribute.

Is creatinine alone enough to diagnose kidney disease?

No. Creatinine is interpreted with eGFR, previous results, urine studies, clinical context and other laboratory tests.

What is eGFR?

eGFR is an estimated glomerular filtration rate calculated from filtration markers such as standardized serum creatinine, often with age and sex, to estimate kidney filtration.

Can creatinine be normal with kidney disease?

Yes. Creatinine may remain within a population reference interval in early kidney disease or in people with low muscle mass. eGFR and UACR can provide additional information.

Can dehydration increase creatinine?

Yes. Dehydration and reduced renal perfusion can increase serum creatinine.

Can exercise increase creatinine?

Intense exercise and muscle injury can influence creatinine, particularly when accompanied by increased muscle breakdown.

What is the difference between Jaffé and enzymatic creatinine?

Jaffé methods use an alkaline picrate reaction and can be affected by non-creatinine chromogens. Enzymatic assays generally improve specificity but still have method-dependent interferences.

Why is cystatin C used?

Cystatin C can provide an additional filtration marker when creatinine-based estimates may be less accurate; combined creatinine–cystatin C equations can improve GFR estimation in selected settings.

What is UACR?

UACR is the urine albumin-to-creatinine ratio. It helps detect albuminuria and complements eGFR in kidney assessment.

Can medications increase creatinine without true kidney failure?

Some medications can alter tubular creatinine handling and raise serum creatinine without a proportional fall in true GFR, while other drugs can cause genuine kidney injury.

Is eGFR accurate during acute kidney injury?

Creatinine-based eGFR is less reliable when serum creatinine is changing rapidly because the patient is not in steady state.

Should high creatinine always be repeated?

Repeat testing depends on the magnitude, clinical context, previous results, specimen quality and laboratory policy. Unexpected or discordant results often warrant verification.

27. Related MedLab Academy Guides

• Vitamin D Blood Test: 25-Hydroxy Vitamin D Levels & Laboratory Interpretation
• High Ferritin Levels: Causes & Laboratory Interpretation
• ESR: Complete Laboratory Guide
• Procalcitonin (PCT): Sepsis Diagnosis & Laboratory Interpretation
• Thyroid Function Tests (TSH, FT3, FT4)
• HbA1c: Diabetes Diagnosis, Monitoring & QC
• Urinalysis (UA): Physical, Chemical & Microscopic Examination
• Hemolysis in Clinical Chemistry
• Internal Quality Control (IQC): Westgard Rules & Levey–Jennings Charts
• Liver Function Tests (LFTs)
• Complete Blood Count (CBC): Parameters & Interpretation
• High Alkaline Phosphatase (ALP) Levels
• High CRP Levels: Causes & Clinical Interpretation
• Laboratory Quality Indicators (QIs): KPIs, ISO 15189 & Quality Management
• High D-Dimer Levels: DVT, PE & Laboratory Interpretation

Authoritative References

The following authoritative resources provide additional guidance on serum creatinine, estimated glomerular filtration rate (eGFR), chronic kidney disease assessment, cystatin C, and laboratory evaluation of kidney function.

1. Kidney Disease: Improving Global Outcomes (KDIGO). 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.
   KDIGO 2024 CKD Guideline
2. National Kidney Foundation (NKF). CKD-EPI Creatinine Equation (2021). Guidance on the race-free CKD-EPI equation using standardized serum creatinine, age, and sex.
   NKF – CKD-EPI Creatinine Equation (2021)
3. National Kidney Foundation (NKF). CKD-EPI Creatinine-Cystatin C Equation (2021). Reference information for combined creatinine and cystatin C estimation of glomerular filtration rate.
   NKF – CKD-EPI Creatinine-Cystatin C Equation (2021)
4. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Glomerular Filtration Rate Equations. Overview of recommended adult and pediatric eGFR equations and laboratory considerations.
   NIDDK – Glomerular Filtration Rate Equations
5. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). eGFR Equations for Adults. Detailed information on the 2021 CKD-EPI creatinine and creatinine-cystatin C equations.
   NIDDK – eGFR Equations for Adults
6. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). eGFR Calculators for Adults & Pediatrics. Clinical calculators and guidance for estimating kidney filtration using contemporary race-free equations.
   NIDDK – eGFR Calculators
7. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). eGFR Equations for Children, Adolescents, & Young Adults. Information on CKiD U25 and other pediatric and young-adult kidney function equations.
   NIDDK – Pediatric & Young Adult eGFR Equations
8. MedlinePlus – U.S. National Library of Medicine. Creatinine Test. Patient-oriented reference covering blood and urine creatinine testing, kidney filtration, and interpretation of abnormal creatinine results.
   MedlinePlus – Creatinine Test

Note: Clinical guidelines, laboratory methods, reference intervals, eGFR reporting practices, and recommendations may change over time. Always consult the latest version of the relevant guideline and the performing laboratory's validated procedures.

Medical Disclaimer: MedLab Academy provides educational laboratory medicine content. Reference intervals, analytical methods, eGFR reporting practices, critical-result policies, and clinical recommendations vary among laboratories, manufacturers, populations, and healthcare systems.

About the Author

Prepared by Dr. Omar Adwan – MedLab Academy

Edit This Article